VanEck Associates’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27K | Buy |
2,415
+249
| +11% | +$2.78K | ﹤0.01% | 1345 |
|
|
2025
Q1 | $21K | Buy |
2,166
+133
| +7% | +$1.29K | ﹤0.01% | 1335 |
|
|
2024
Q4 | $23K | Buy |
2,033
+677
| +50% | +$7.66K | ﹤0.01% | 1333 |
|
|
2024
Q3 | $30K | Sell |
1,356
-677
| -33% | -$15K | ﹤0.01% | 1300 |
|
|
2024
Q2 | $39K | Sell |
2,033
-345
| -15% | -$6.62K | ﹤0.01% | 1302 |
|
|
2024
Q1 | $78K | Buy |
2,378
+61
| +3% | +$2K | ﹤0.01% | 1249 |
|
|
2023
Q4 | $77K | Buy |
2,317
+222
| +11% | +$7.38K | ﹤0.01% | 1258 |
|
|
2023
Q3 | $57K | Buy |
2,095
+323
| +18% | +$8.79K | ﹤0.01% | 1272 |
|
|
2023
Q2 | $54K | Sell |
1,772
-264
| -13% | -$8.05K | ﹤0.01% | 1299 |
|
|
2023
Q1 | $66K | Buy |
2,036
+99
| +5% | +$3.21K | ﹤0.01% | 1288 |
|
|
2022
Q4 | $54K | Buy |
+1,937
| New | +$54K | ﹤0.01% | 1309 |
|